Status:
COMPLETED
The Effect of Mobile Application Robot Developed for Pediatric Diabetes Management on Children With Diabetes Mellitus
Lead Sponsor:
Dokuz Eylul University
Collaborating Sponsors:
Necmettin Erbakan University
Conditions:
Diabetes Mellitus, Type 1
Children
Eligibility:
All Genders
7-12 years
Phase:
NA
Brief Summary
Type 1 DM; It is a chronic metabolic disease that develops as a result of the destruction of pancreatic ß cells, which are responsible for insulin production. Although type 1 DM can occur at any age, ...
Detailed Description
Type 1 DM; It is a chronic metabolic disease that develops as a result of the destruction of pancreatic ß cells, which are responsible for insulin production. Although type 1 DM can occur at any age, ...
Eligibility Criteria
Inclusion
- Be in the 7-12 age range
- Understanding and speaking Turkish
- No vision or hearing problems
- Having been diagnosed with Type 1 Diabetes Mellitus at least six months ago
- Parents and children must have an internet connection, computer, smartphone or tablet to use the Diabot application
Exclusion
- The children who will participate in the research have another chronic disease together with diabetes,
- The children who will participate in the study have a neurological disease together with diabetes,
- No internet connection and no smartphone or tablet,
- Not having the ability to use the application.
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05333393
Start Date
May 1 2023
End Date
July 1 2024
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necmettin Erbakan University Medical Faculty Hospital
Konya, Meram, Turkey (Türkiye), 42080